Pablo Lee, MD

Chimerix
Durham, NC

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2483 - Response to ONC201 by Prior Radiotherapy Regimen in Recurrent H3 K27M-Mutant Diffuse Midline Glioma

  Monday, September 30, 2024
  10:45 AM – 12:00 PM ET